Commission Hearing: Technology and Innovation for NCD Risk Reduction

The Vitality Institute Commission Hearing: Technology and Innovation for NCD Risk Reduction September 19, 2013; 9am-12pm New York Academy of Sciences (NYAS) 7 World Trade Center, 250 Greenwich Street, 40th floor New York, NY 10007-2157

Description

This Hearing hosted by the Vitality Institute Commission on the Prevention of Chronic Diseases in Working Age Americans will focus on technology-based innovations to advance prevention and health promotion in relation to major chronic disease risks. Guests include experts and leaders focused on technology to reduce disease risks including diet, tobacco control, mental health, physical activity, and medication adherence.

The NYAS and the Institute for the Future will present preliminary research findings on technologies that are “quick wins” based on evidence of impact, and consider what it will take to scale these and to reach people at all educational and income levels. Selected commissioners with expertise in technology innovation will share responses, followed by a moderated group discussion. Discussions will focus on: - Measures to improve primary prevention as well as secondary prevention. - Advances in science able to improve diets, tobacco control, mental health, physical activity, and adherence including technologies at the interface of these advances with a focus on connectivity to individuals and providers. - Landscape assessment on innovative technology available today.

Agenda

Time Item Speaker 9am Welcome Derek Yach, Executive Director, The Vitality Institute Will Rosenzweig, Commission Chair and Managing Partner at Physic Ventures, LP 9:05am Report on the tech innovations work Mandana Arabi, Founding Executive Director of The Sackler underway for the Commission Institute for Nutrition Science, New York Academy of Sciences Richard Adler, Distinguished Fellow, Institute for the Future 10:05am Ilene Klein, Director of Global Employee Health Services, Qualcomm 10:10am Oliver Moses, Senior Managing Director, MTS Health Investors, LLC Prepared responses by Commissioners 10:15am Ellis Rubinstein, President and CEO, New York Academy of Sciences 10:20am Dennis Schmuland, Chief Health Strategy Officer for the US Health and Life Sciences Division, Microsoft 10:25am Break 10:40am Moderated Discussion Group 11:40am Intern Innovation team presentations Summer 2013 innovation interns 11:50am Wrap-Up Derek Yach, Executive Director, The Vitality Institute Will Rosenzweig, Commission Chair and Managing Partner at Physic Ventures, LP Future Commission Hearings

Date Meeting Location Collaborators September 19 Hearing: Technology and innovation for NCD risk New York, NY New York Academy of reduction Sciences September 19/20 September 19/20 New York, NY New York Academy of Sciences October 2013 CDC hearing: promoting chronic disease Atlanta, GA Emory University prevention on the national level Fall 2013 DC hearing: promoting chronic disease Washington DC Georgetown University prevention on the national level Law School November 2013 Hearing: Business for health Denver, CO Denver Chamber of Commerce Fall 2013 Awaiting confirmation: Hearing: Local health Louisville, KY Humana challenges and opportunities

Jan/Feb 2014 Hearing: Technology and innovation for NCD risk San Francisco, CA Google reduction Early 2014 Hearing: Health, wellness and wellbeing San Francisco, CA None Defined